PAC1021Tissue Micro Arrays

PAC1021

Pancreatic cancer tissue array contains 86 cases of malignant tumors, 10 cases of benign tumors, 5 cases of normal tissues, and 1 case inflammatory pancreatic tissue with grading and TNM staging data.

Specifications

Price per slide:

$352

Species:

Human

Cases:

102 Cores:

102 Core Size:

1.5mm

Core Thickness:

4um

Rows:

8 Columns:

13 Format:

Learn More

Intended Usage:

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in pancreas cancers.

8 X

13

For illustration purpose only. Actual product may vary.

Notes:

All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.

Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.

Download Data sheet

Download MSDS

ARRAY POSITION	SEX	AGE	ANATOMIC SITE	PATHOLOGY	NATURE	GRADE	STAGE (TNM)
A01	M	31	Pancreas	Normal	Normal
A02	F	63	Pancreas	Normal	Normal
A03	F	59	Pancreas	Normal	Normal
A04	M	35	Pancreas	Normal	Normal
A05	M	44	Pancreas	Normal	Normal
A06	M	36	Pancreas	Chronic inflammation	Inflammatory
A07	F	39	Pancreas	Paraganglioma	Benign
A08	F	47	Pancreas	Mucinous cystadenoma	Benign
A09	F	56	Pancreas	Serous cystadenoma	Benign
A10	F	76	Pancreas	Gastrointestinal stromal tumor, GIST	Malignant
A11	F	45	Pancreas	Hemangioma	Benign
A12	M	30	Pancreas	Islet cell tumor	Benign
A13	M	54	Pancreas	Islet cell tumor	Benign
B01	M	42	Pancreas	Islet cell tumor	Benign
B02	F	45	Pancreas	Neuroendocrine carcinoma	Malignant		T2N0M0
B03	F	28	Pancreas	Islet cell tumor	Benign
B04	F	20	Pancreas	Neuroendocrine carcinoma	Malignant		T2N0M0
B05	M	30	Pancreas	Mixed acinar-endocrine carcinoma	Malignant		T2N0M0
B06	F	60	Pancreas	Neuroendocrine carcinoma	Malignant		T3N1M0
B07	F	40	Pancreas	Neuroendocrine carcinoma	Malignant		T2N0M0
B08	F	59	Pancreas	Islet cell tumor	Benign
B09	M	56	Pancreas	Islet cell tumor	Benign
B10	M	59	Pancreas	Neuroendocrine carcinoma	Malignant	I	T2N1M0
B11	F	36	Pancreas	Mixed acinar-endocrine carcinoma	Malignant		T2N0M0
B12	F	52	Pancreas	Papillary carcinoma	Malignant		T2N0M0
B13	F	21	Pancreas	Solid-pseudopapillary tumor	Malignant	I	T2N0M0
C01	F	37	Pancreas	Solid-pseudopapillary tumor	Malignant	I	T4N1M0
C02	M	39	Pancreas	Serous cystadenocarcinoma	Malignant		T4N0M0
C03	M	51	Pancreas	Mucinous cystadenocarcinoma	Malignant		T2N0M0
C04	F	61	Pancreas	Mucinous cystadenocarcinoma	Malignant		T2N0M0
C05	F	65	Pancreas	Ductal adenocarcinoma	Malignant	I	T3N0M0
C06	M	43	Pancreas	Ductal adenocarcinoma	Malignant	I	T2N0M0
C07	M	55	Pancreas	Ductal adenocarcinoma	Malignant	I	T4N0M0
C08	M	80	Pancreas	Ductal adenocarcinoma	Malignant	I	T4N1M0
C09	F	57	Pancreas	Ductal adenocarcinoma	Malignant	I	T2N0M0
C10	M	64	Pancreas	Ductal adenocarcinoma	Malignant	I	T2N0M0
C11	F	77	Pancreas	Ductal adenocarcinoma	Malignant	I	T2N0M0
C12	F	44	Pancreas	Ductal adenocarcinoma	Malignant	I	T3N0M0
C13	M	63	Pancreas	Ductal adenocarcinoma	Malignant	I
D01	F	19	Pancreas	Acinar cell carcinoma	Malignant	I~II	T2N0M0
D02	M	63	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T3N1M0
D03	M	46	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T3N0M0
D04	M	42	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T4N0M0
D05	M	63	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T3N0M0
D06	M	56	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T3N0M0
D07	F	57	Pancreas	Ductal adenocarcinoma	Malignant	I~II	T2N1M0
D08	F	49	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N1M1
D09	M	40	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N1M0
D10	F	40	Pancreas	Ductal adenocarcinoma	Malignant	II	T4N0M1
D11	F	60	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N1M1
D12	M	65	Pancreas	Ductal adenocarcinoma	Malignant	II	T4N0M0
D13	F	58	Pancreas	Ductal adenocarcinoma	Malignant	II	T4N0M0
E01	M	58	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M0
E02	M	62	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N1M0
E03	M	65	Pancreas	Ductal adenocarcinoma	Malignant	II	T2N0M0
E04	M	84	Pancreas	Ductal adenocarcinoma	Malignant	II	T4N0M0
E05	F	45	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M0
E06	M	60	Pancreas	Ductal adenocarcinoma	Malignant	II	T2N0M0
E07	F	64	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N1M0
E08	F	62	Pancreas	Ductal adenocarcinoma	Malignant	II	T2N1M0
E09	F	55	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N1M0
E10	M	62	Pancreas	Mucinous adenocarcinoma	Malignant	II	T3N1M1
E11	M	67	Pancreas	Ductal adenocarcinoma	Malignant	II	T2N0M0
E12	M	62	Pancreas	Ductal adenocarcinoma	Malignant	II
E13	M	50	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M1
F01	F	28	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M1
F02	M	68	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M1
F03	M	72	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M1
F04	F	70	Pancreas	Ductal adenocarcinoma	Malignant	II	T3N0M1
F05	F	63	Pancreas	Ductal adenocarcinoma	Malignant	II
F06	M	76	Pancreas	Ductal adenocarcinoma	Malignant	II	T2N0M0
F07	M	73	Pancreas	Ductal adenocarcinoma	Malignant	II	T4N0M1
F08	F	58	Pancreas	Ductal adenocarcinoma	Malignant	II
F09	M	69	Pancreas	Ductal adenocarcinoma	Malignant	II
F10	M	63	Pancreas	Ductal adenocarcinoma	Malignant	II
F11	F	75	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T2N1M0
F12	M	56	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T2N0M0
F13	M	73	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N0M0
G01	M	40	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N1M0
G02	M	65	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T2N1M0
G03	F	68	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N1M0
G04	F	59	Pancreas	Ductal adenocarcinoma	Malignant	II~III	T3N0M1
G05	F	50	Pancreas	Ductal adenocarcinoma	Malignant	II-III	T2N0M0
G06	F	71	Pancreas	Ductal adenocarcinoma	Malignant	II-III
G07	M	69	Pancreas	Ductal adenocarcinoma	Malignant	II-III	T3N0M1
G08	M	55	Pancreas	Ductal adenocarcinoma	Malignant	II-III
G09	M	51	Pancreas	Ductal adenocarcinoma	Malignant	III	T2N0M0
G10	M	70	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N1M0
G11	M	53	Pancreas	Ductal adenocarcinoma	Malignant	III	T2N0M0
G12	F	64	Pancreas	Ductal adenocarcinoma	Malignant	III	T2N0M0
H01	F	66	Pancreas	Ductal adenocarcinoma	Malignant	III	T4N1M0
H02	F	52	Pancreas	Ductal adenocarcinoma	Malignant	III	T4N0M0
H03	F	65	Pancreas	Ductal adenocarcinoma	Malignant	III	T2N0M0
H04	F	38	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N1M0
H05	F	57	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N1M0
H06	F	57	Pancreas	Metastatic stomach adenocarcinoma	Metastasis	III
H07	M	61	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N0M0
H08	M	72	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N0M1
H09	M	45	Pancreas	Ductal adenocarcinoma	Malignant	III	T3N0M1
H10	M	48	Pancreas	Ductal adenocarcinoma	Malignant	III
H11	M	58	Pancreas	Undifferentiated carcinoma	Malignant	IV	T2N0M0
H12	F	74	Pancreas	Undifferentiated carcinoma	Malignant	IV	T4N1M0

GENERAL INFORMATION

CONTROL TMA

ANIMALS

NATURE

BY LETTER

ANATOMIC SYSTEM

ANATOMIC SITE

SERVICES

CUSTOM TMA

IMAGING / PATHOLOGY ANALYSIS

ROUTINE PATHOLOGY

IHC / IMMUNOFLUORESCENCE

ISH / FISH

CONTRACTED SERVICES

PRIMARY IHC ANTIBODIES

PATHOLOGY FIELD

Hermatopathology

DETECTION SYSTEMS

ANCILLARIES

CONTROL TMA

SPECIES

GENERAL INFORMATION

BY LETTER

NATURE

ANATOMIC SYSTEM

ANATOMIC SITE

GENERAL INFORMATION

BY LETTER

NATURE

ANATOMIC SYSTEM

ANATOMIC SITE

PAC1021

Pancreatic cancer tissue array contains 86 cases of malignant tumors, 10 cases of benign tumors, 5 cases of normal tissues, and 1 case inflammatory pancreatic tissue with grading and TNM staging data.

Price per slide:

$352

Species:

Human

Cases:

102

Cores:

102

Core Size:

1.5mm

Core Thickness:

4um

Rows:

8

Columns:

13

Format:

Intended Usage:

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in pancreas cancers.

8

X

13

For illustration purpose only. Actual product may vary.

Notes:

​

Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.

Download Data sheet

Download MSDS

1049 Union Ave. Suite D

Fairfield, CA 94533

Tel: (415) 863-2380

Fax: (510) 225-1084

E-mail:

HELPFUL LINKS

​

ABOUT US

CONTACT US

​

LEGAL​

​

© 2021 Pantomics Inc.

LEGAL